Unauthorized products seized from Herc's Nutrition in Brampton because they may pose serious risks to health

Starting date:
March 14, 2016
Posting date:
March 14, 2016
Type of communication:
Natural health products
Source of recall:
Health Canada
Important Safety Information, Unauthorized products
General Public
Identification number:


Health Canada seized six unauthorized products being promoted as dietary supplements (see table below) from Herc's Nutrition, 175 Fletchers Creek Blvd., Brampton, Ontario. These products may pose serious risks to the health of Canadians.

Products affected:
Product Ingredient Photo
RapidFire Yohimbine and ephedra RapidFire
Black Magic Yohimbine and ephedra Black Magic
China White Yohimbine and ephedra China White
Hydroxycut Hardcore Next Gen Yohimbine Hydroxycut Hardcore Next Gen
Psychotic Yohimbine Psychotic
Lipo-Cuts Yohimbe and ephedra Lipo-Cuts

What you should do

  • Consult with your doctor if you have used these products and have health concerns.
  • Read the product label to verify that health products have been authorized for sale by Health Canada have an eight-digit DIN, a DIN-HM or a NPN.
  • Verify if products that have been authorized for sale by searching the Drug Product Database and the Licensed Natural Health Product Database.
  • Report any adverse events to Health Canada.
  • Report complaints about health products to Health Canada by calling toll-free to 1-800-267-9675, or complete an online complaint form.

Who is affected

Consumers who have bought or used any of the affected products.


The use of drugs containing yohimbine (either as yohimbine hydrochloride or yohimbe bark extract) may result in serious adverse reactions, particularly in people with high blood pressure, heart, kidney or liver disease. Side effects associated with yohimbine include increased blood pressure and heart rate, anxiety, dizziness, tremors, headache, nausea and sleep disorders. It should not be used by children, pregnant or nursing women.

Use of products containing ephedra/ephedrine is not recommended in people with heart problems, hypertension, thyroid disease, diabetes, enlarged prostate, anxiety and restlessness, glaucoma (serious eye disorder) and pheochromocytoma (serious gland disorder) because ephedra/ephedrine aggravates these conditions. Consumers should use ephedra/ephedrine products only for the approved indication of nasal decongestion, and should not exceed the maximum allowable dosage described in the ephedra and ephedrine/pseudoephedrine labelling standards, unless this has been recommended by -- and you are under the care of -- a health care practitioner. These products should also be avoided during pregnancy and lactation.

Report health or safety concerns

  • Call toll-free at 1-866-234-2345
  • Visit MedEffect Canada's web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.

Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.

Media enquiries

Health Canada

Public enquiries


What Health Canada is doing

Health Canada has seized the products from the retail location. Should additional retailers or distributors of these products be identified, Health Canada will take appropriate action and inform Canadians.


Select thumbnail to enlarge - opens in a new window